{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T20:37:07Z","timestamp":1783370227596,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00210-025-04053-7","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T03:02:41Z","timestamp":1746068561000},"page":"15269-15286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["QbD assisted development of hyaluronic acid and TPGS incorporated DOX liposome(s): in vitro assessment of cytotoxicity, uptake, ROS, and NF-\u03baB potential on MDA-MB-231 cells"],"prefix":"10.1007","volume":"398","author":[{"given":"Lakshmi","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balak","family":"Das Kurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"issue":"3","key":"4053_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jbm.a.32734","volume":"94","author":"V Anbharasi","year":"2010","unstructured":"Anbharasi V, Cao N, Feng SS (2010) Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy. J Biomed Mater Res A 94(3):730\u2013743. https:\/\/doi.org\/10.1002\/jbm.a.32734","journal-title":"J Biomed Mater Res A"},{"issue":"41","key":"4053_CR2","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.1039\/C7TB01895A","volume":"5","author":"D Bhattacharya","year":"2017","unstructured":"Bhattacharya D, Svechkarev D, Souchek JJ et al (2017) Impact of structurally modifying hyaluronic acid on CD44 interaction. J Mater Chem B 5(41):8183\u20138192. https:\/\/doi.org\/10.1039\/C7TB01895A","journal-title":"J Mater Chem B"},{"issue":"Suppl 6","key":"4053_CR3","doi-asserted-by":"publisher","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","volume":"23","author":"P Boyle","year":"2012","unstructured":"Boyle P (2012) Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol 23(Suppl 6):vi7-12. https:\/\/doi.org\/10.1093\/annonc\/mds187. (PubMed PMID: 23012306)","journal-title":"Ann Oncol"},{"issue":"28","key":"4053_CR4","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1016\/j.biomaterials.2008.05.016","volume":"29","author":"N Cao","year":"2008","unstructured":"Cao N, Feng SS (2008) Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 29(28):3856\u20133865. https:\/\/doi.org\/10.1016\/j.biomaterials.2008.05.016","journal-title":"Biomaterials"},{"issue":"17","key":"4053_CR5","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2165\/11538150-000000000-00000","volume":"70","author":"S Dawood","year":"2010","unstructured":"Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70(17):2247\u20132258. https:\/\/doi.org\/10.2165\/11538150-000000000-00000. (PubMed PMID: 21080741)","journal-title":"Drugs"},{"issue":"1\u20132","key":"4053_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijpharm.2012.11.031","volume":"441","author":"J Dong","year":"2013","unstructured":"Dong J, Jiang D, Wang Z et al (2013J 30) Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model. Int J Pharm 441(1\u20132):285\u2013290. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.11.031","journal-title":"Int J Pharm"},{"issue":"3","key":"4053_CR7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/ijms22031257","volume":"22","author":"V Gote","year":"2021","unstructured":"Gote V, Sharma AD, Pal D (2021) Hyaluronic acid-targeted stimuli-sensitive nanomicelles co-encapsulating paclitaxel and ritonavir to overcome multi-drug resistance in metastatic breast cancer and triple-negative breast cancer cells. Int J Mol Sci 22(3):1257. https:\/\/doi.org\/10.3390\/ijms22031257","journal-title":"Int J Mol Sci"},{"key":"4053_CR8","doi-asserted-by":"publisher","unstructured":"Hassn Mesrati M, Syafruddin SE, Mohtar MA, Syahir A (2021) CD44: a multifunctional mediator of cancer progression. Biomolecules 11(12):1850. https:\/\/doi.org\/10.3390\/biom11121850","DOI":"10.3390\/biom11121850"},{"issue":"23","key":"4053_CR9","doi-asserted-by":"publisher","first-page":"34158","DOI":"10.18632\/oncotarget.8926","volume":"7","author":"SL Hayward","year":"2016","unstructured":"Hayward SL, Wilson CL, Kidambi S (2016) Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells. Oncotarget 7(23):34158\u201334171. https:\/\/doi.org\/10.18632\/oncotarget.8926","journal-title":"Oncotarget"},{"key":"4053_CR10","doi-asserted-by":"publisher","unstructured":"Ibrahim M, Abuwatfa WH, Awad NS, et al (2022) Encapsulation, release, and cytotoxicity of doxorubicin loaded in liposomes, micelles, and metal-organic frameworks: a review. Pharmaceutics 14(2):254. https:\/\/doi.org\/10.3390\/pharmaceutics14020254.","DOI":"10.3390\/pharmaceutics14020254"},{"issue":"4","key":"4053_CR11","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s00210-023-02752-7","volume":"397","author":"F Khosravani","year":"2024","unstructured":"Khosravani F, Amiri F, Mahmoudi R et al (2024) RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 397(4):2347\u20132357. https:\/\/doi.org\/10.1007\/s00210-023-02752-7","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"2","key":"4053_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/08982104.2021.1903034","volume":"32","author":"BD Kurmi","year":"2022","unstructured":"Kurmi BD, Paliwal SR (2022) Development and optimization of TPGS-based stealth liposome of doxorubicin using Box-Behnken design: characterization, hemocompatibility, and cytotoxicity evaluation in breast cancer cells. J Liposome Res 32(2):129\u2013145. https:\/\/doi.org\/10.1080\/08982104.2021.1903034","journal-title":"J Liposome Res"},{"issue":"164","key":"4053_CR13","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1016\/j.ijbiomac.2020.08.172","volume":"1","author":"BD Kurmi","year":"2020","unstructured":"Kurmi BD, Paliwal R, Paliwal SR (2020) Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach. Int J Biol Macromol 1(164):2881\u20132894. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.08.172","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"4053_CR14","doi-asserted-by":"publisher","first-page":"e21970","DOI":"10.7759\/cureus.21970","volume":"14","author":"I Landry","year":"2022","unstructured":"Landry I, Sumbly V, Vest M (2022) Advancements in the treatment of triple-negative breast cancer: a narrative review of the literature. Cureus 14(2):e21970. https:\/\/doi.org\/10.7759\/cureus.21970","journal-title":"Cureus"},{"issue":"17","key":"4053_CR15","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.18632\/oncotarget.2166","volume":"5","author":"P Liu","year":"2014","unstructured":"Liu P, Wang Z, Brown S et al (2014) Liposome encapsulated Disulfiram inhibits NFkappaB pathway and targets breast cancer stem cells in vitro and in vivo. Oncotarget 5(17):7471\u20137485. https:\/\/doi.org\/10.18632\/oncotarget.2166","journal-title":"Oncotarget"},{"issue":"8","key":"4053_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1177\/0885328220976331","volume":"35","author":"R Mahmoudi","year":"2021","unstructured":"Mahmoudi R, Hassandokht F, Ardakani MT et al (2021) Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells. J Biomater Appl 35(8):1005\u20131018. https:\/\/doi.org\/10.1177\/0885328220976331","journal-title":"J Biomater Appl"},{"key":"4053_CR17","doi-asserted-by":"publisher","first-page":"119895","DOI":"10.1016\/j.ijpharm.2020.119895","volume":"590","author":"M Malakouti-Nejad","year":"2020","unstructured":"Malakouti-Nejad M, Bardania H, Aliakbari F et al (2020) Formulation of nanoliposome-encapsulated bevacizumab (Avastin): statistical optimization for enhanced drug encapsulation and properties evaluation. Int J Pharm 590:119895. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119895","journal-title":"Int J Pharm"},{"key":"4053_CR18","doi-asserted-by":"publisher","first-page":"100349","DOI":"10.1016\/j.mtbio.2022.100349","volume":"16","author":"A Mansoori-Kermani","year":"2022","unstructured":"Mansoori-Kermani A, Khalighi S, Akbarzadeh I et al (2022) Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer. Mater Today Bio 16:100349. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100349","journal-title":"Mater Today Bio"},{"issue":"3","key":"4053_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jconrel.2013.01.035","volume":"169","author":"Y Mi","year":"2013","unstructured":"Mi Y, Zhao J, Feng SS (2013) Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. J Control Release 169(3):185\u2013192. https:\/\/doi.org\/10.1016\/j.jconrel.2013.01.035","journal-title":"J Control Release"},{"issue":"4","key":"4053_CR20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/cancers13040898","volume":"13","author":"G Nabil","year":"2021","unstructured":"Nabil G, Alzhrani R, Alsaab HO et al (2021) CD44 targeted nanomaterials for treatment of triple-negative breast cancer. Cancers (Basel) 13(4):898. https:\/\/doi.org\/10.3390\/cancers13040898","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4053_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/molecules23040907","volume":"23","author":"TOB Olusanya","year":"2018","unstructured":"Olusanya TOB, Haj Ahmad RR, Ibegbu DM et al (2018) Liposomal drug delivery systems and anticancer drugs. Mol 23(4):907. https:\/\/doi.org\/10.3390\/molecules23040907","journal-title":"Mol"},{"key":"4053_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.steroids.2015.05.012","volume":"101","author":"M Pradhan","year":"2015","unstructured":"Pradhan M, Singh D, Murthy SN et al (2015) Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis. Steroids 101:56\u201363. https:\/\/doi.org\/10.1016\/j.steroids.2015.05.012","journal-title":"Steroids"},{"issue":"36","key":"4053_CR23","doi-asserted-by":"publisher","first-page":"23437","DOI":"10.1021\/acsami.6b04179","volume":"8","author":"S Pulakkat","year":"2016","unstructured":"Pulakkat S, Balaji SA, Rangarajan A et al (2016) Surface engineered protein nanoparticles with hyaluronic acid based multilayers for targeted delivery of anticancer agents. ACS Appl Mater Interfaces 8(36):23437\u201323449. https:\/\/doi.org\/10.1021\/acsami.6b04179","journal-title":"ACS Appl Mater Interfaces"},{"key":"4053_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-2422-6_1","volume":"1280","author":"S Ramaswami","year":"2015","unstructured":"Ramaswami S, Hayden MS (2015) Electrophoretic mobility shift assay analysis of NF-kappaB DNA binding. Methods Mol Biol 1280:3\u201313. https:\/\/doi.org\/10.1007\/978-1-4939-2422-6_1. (PubMed PMID: 25736740)","journal-title":"Methods Mol Biol"},{"issue":"229","key":"4053_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","volume":"10","author":"F Ravar","year":"2016","unstructured":"Ravar F, Saadat E, Gholami M et al (2016) Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release 10(229):10\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2016.03.012","journal-title":"J Control Release"},{"key":"4053_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat PS, Jaiswal A, Khurana A et al (2021) Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. Biomedicine Pharmacotherapy 139:111708","journal-title":"Biomedicine Pharmacotherapy"},{"key":"4053_CR27","doi-asserted-by":"publisher","unstructured":"Sandal P, Kumari L, Patel P, et al (2023) Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. ASSAY Drug Dev Technol. https:\/\/doi.org\/10.1089\/adt.2022.102","DOI":"10.1089\/adt.2022.102"},{"key":"4053_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101179","volume":"53","author":"M Song","year":"2019","unstructured":"Song M, Liang Y, Li K et al (2019) Hyaluronic acid modified liposomes for targeted delivery of doxorubicin and paclitaxel to CD44 overexpressing tumor cells with improved dual-drugs synergistic effect. Journal of Drug Delivery Science Technology 53:101179","journal-title":"Journal of Drug Delivery Science Technology"},{"issue":"2","key":"4053_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157\u2013170. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01567.x","journal-title":"J Pharm Pharmacol"},{"issue":"130","key":"4053_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lfs.2015.03.016","volume":"1","author":"D Thummuri","year":"2015","unstructured":"Thummuri D, Kumar S, Surapaneni SK et al (2015) Epigenetic regulation of protein tyrosine phosphatase PTPN12 in triple-negative breast cancer. Life Sci 1(130):73\u201380. https:\/\/doi.org\/10.1016\/j.lfs.2015.03.016","journal-title":"Life Sci"},{"key":"4053_CR31","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.2147\/IJN.S82847","volume":"10","author":"Y Wu","year":"2015","unstructured":"Wu Y, Chu Q, Tan S et al (2015) D-alpha-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Int J Nanomed 10:5219\u20135235. https:\/\/doi.org\/10.2147\/IJN.S82847","journal-title":"Int J Nanomed"},{"issue":"2","key":"4053_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7150\/thno.22711","volume":"8","author":"C Yang","year":"2018","unstructured":"Yang C, Wu T, Qi Y et al (2018) Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics 8(2):464\u2013485. https:\/\/doi.org\/10.7150\/thno.22711","journal-title":"Theranostics"},{"key":"4053_CR33","first-page":"1344","volume":"28","author":"Y-X Zhao","year":"2017","unstructured":"Zhao Y-X, Guo C-L, Yao W-T et al (2017) TPGS based liposomal delivery of doxorubicin in osteosarcoma cancer cells. Biomed Res 28:1344\u20131349","journal-title":"Biomed Res"},{"key":"4053_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.phrs.2017.07.011","volume":"126","author":"Z Zhu","year":"2017","unstructured":"Zhu Z, Li Y, Yang X et al (2017) The reversion of anti-cancer drug antagonism of tamoxifen and docetaxel by the hyaluronic acid-decorated polymeric nanoparticles. Pharmacol Res 126:84\u201396. https:\/\/doi.org\/10.1016\/j.phrs.2017.07.011","journal-title":"Pharmacol Res"},{"issue":"173","key":"4053_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.colsurfb.2018.10.044","volume":"1","author":"GK Zorzi","year":"2019","unstructured":"Zorzi GK, Schuh RS, Maschio VJ et al (2019) Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba. Colloids Surf B Biointerfaces 1(173):725\u2013732. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.10.044","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04053-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:14:15Z","timestamp":1761304455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04053-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4053"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04053-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}